Identification of ALK as the Major Familial Neuroblastoma Predisposition Gene
By Yalë P Mossë, M. Laudenslager, L. Longo, K. Cole, A. Wood, E. Attiyeh, M. Laquaglia, Rachel Sennett, Jill E. Lynch, P. Perri and 10 more. Nature, 2008
1,410 citations recorded by the source corpus.
Neuroblastoma is a childhood cancer that can be inherited, but the genetic aetiology is largely unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK) gene explain most hereditary neuroblastomas, and that activating mutations can also be somatically acquired. We first identified a significant linkage signal at chromosome bands 2p23–24 using a whole-genome scan in neuroblastoma pedigrees. Resequencing of regional candidate genes identified three separate germline missense mutations in the tyrosine kinase domain of ALK that segregated with the disease in eight separate families. Resequencing in 194 high-risk neuroblastoma samples showed somatically acquired mutations in the tyrosine kinase domain in 12.4% of samples. Nine of the ten mutations map to critical regions of the kinase domain and were predicted, with high probability, to be oncogenic drivers. Mutations resulted in constitutive phosphorylation, and targeted knockdown of ALK messenger RNA resulted in profound inhibition of growth in all cell lines harbouring mutant or amplified ALK, as well as in two out of six wild-type cell lines for ALK. Our results demonstrate that heritable mutations of ALK are the main cause of familial neuroblastoma, and that germline or acquired activation of this cell-surface kinase is a tractable therapeutic target for this lethal paediatric malignancy.
Subfields: Cancer Research, Molecular Biology, Neurology
View Paper: https://www.semanticscholar.org/paper/6f24b15fb3ef4cba014a0e5bbe68937226ad4814
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Miller Huang
Citations in the corpus
- Neuroblastoma and MYCN (2013, background): “Gain of function mutations in the receptor tyrosine kinase ALK (chromosome 2p23) occur in 50% of familial neuroblastoma cases, and 7% of sporadic neuroblastoma cases (Chen et al. 2008; George et al. 2008; Janoueix-Lerosey et al. 2008; Mossé et al. 2008; Molenaaret al. 2012b).”
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer (2010, neutral): “(%)‡ Never 62 (76) ≤10 pack-yr 15 (18) >10 pack-yr 5 (6)”